Continuous glucose dynamics monitoring in diabetic patients with peritoneal dialysis

Authors

  • Somporn Wongraoprasert Faculty of Medicine, Chulalongkorn University
  • Talerngsak Karnjanabuch Faculty of Medicine, Chulalongkorn University
  • Napat Leeaphorn Bassett Medical Center and Columbia University College of Physicians and Surgeons, Cooperstown, USA
  • Kuakoon Piyachomkwan Cassava and Starch Technology Research Unit, National Center for Genetic Engineering and Biotechnology, Pathum Thani, Thailand
  • Sompongse Suwanwalaikorn Faculty of Medicine, Chulalongkorn University
  • Somchai Eiam-Ong Faculty of Medicine, Chulalongkorn University
  • Krit Pongpirul Faculty of Medicine, Chulalongkorn University and Johns Hopkins Bloomberg School of Public Health, Baltimore, USA

Keywords:

Blood glucose, diabetes mellitus, extracellular fluid, peritoneal dialysis

Abstract

Background : Glucose dynamics in patients on peritoneal dialysis (PD) is influenced by many factors.

Objectives : We evaluated the dynamics of interstitial fluid (ISF) glucose in diabetic patients undergoing PD, controlled for caloric food intake, daily activities, and hypoglycemic agents.

Methods : We studied all type-2 diabetic patients at the PD clinic of King Chulalongkorn Memorial Hospital between 2007 and 2008. They received 1.5% or 4.25% glucose during continuous ambulatory peritoneal dialysis (CAPD 1.5% or 4.25%), or 1.5% glucose continuous cycling peritoneal dialysis (CCPD 1.5%). Continuous glucose monitoring system and finger-stick were used to assess ISF and blood glucose levels for 72 hours, respectively. Sixteen patients (9 CAPD and 7 CCPD) were assessed.

Results : Median age, diabetes onset, and years on PD were 71, 17, and 1.5 years, respectively. There was strong correlation between ISF and blood glucose level (r = 0.937). The mean ISF glucose levels between dialysate and non-dialysate days were not significantly different (P = 0.08) in spite of higher total caloric intake on dialysate day (P = 0.049). However, in the CAPD 4.25% group, mean ISF glucose and total consumed calories were significantly higher on dialysate than non-dialysate day (P = 0.026 and 0.031, respectively). The difference disappeared after adjustment for food calories. ISF glucose started rising after a 15-minute infusion of dialysate then sustained till 4 hours with a mean increase of 55%.

Conclusions : The evidence suggested that high-glucose peritoneal dialysate can increase ISF glucose but the effect is confounded by food caloric intake.

Downloads

Download data is not yet available.

References

Dasgupta MK. Management of patients with type 2 diabetes on peritoneal dialysis. Adv Perit Dial 2005;21:120-2.

Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, et al. Performance evaluation of the minimed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000;2:49-56. https://doi.org/10.1089/152091500316737

McGahan L. Continuous glucose monitoring in the management of diabetes mellitus. Issues Emerg Health Technol 2002:1-4.

Poolsup N, Suksomboon N, Kyaw AM. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (cgm) on glucose control in diabetes. Diabetol Metab Syndr 2013; 5:39.

https://doi.org/10.1186/1758-5996-5-39

Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW. Glycemic control in diabetic capd patients assessed by continuous glucose monitoring system (cgms). Kidney Int 2003; 64:1480-6.

https://doi.org/10.1046/j.1523-1755.2003.00209.x

Schwing WD, Erhard P, Newman LN, Nodge MM, Czechanski BJ, Orlin SM, et al. Assessing 24-hour blood glucose patterns in diabetic paitents treated by peritoneal dialysis. Adv Perit Dial 2004; 20:213-6.

Skubala A, Zywiec J, Zelobowska K, Gumprecht J, Grzeszczak W. Continuous glucose monitoring system in 72-hour glucose profile assessment in patients with end-stage renal disease on maintenance continuous ambulatory peritoneal dialysis. Med Sci Monit 2010; 16.

Lee S, Chen Y, Tsai I, Yen C, Chueh S, Chuang H. Glycosylated hemoglobin and albumincorrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients. PLoS One 2013; 8:e57762. https://doi.org/10.1371/journal.pone.0057762

Harris JA, Benedict FG. A biometric study of human basal metabolism. Proc Natl Acad Sci U S A 1918;4:370-3. https://doi.org/10.1073/pnas.4.12.370

Reeves MM, Capra S. Predicting energy requirements in the clinical setting: Are current methods evidence based? Nutr Rev 2003; 61:143-51. https://doi.org/10.1301/nr.2003.apr.143-151

Fortes PC, Mendes JG, Gevert F, Aita C, Riella MC, Pecoits-Filho R. Continuous glycemic monitoring system (cgms) utility in diabetic patients undergoing peritoneal dialysis. Perit Dial Int 2007; 27:S14.

Downloads

Published

2023-08-24

How to Cite

1.
Wongraoprasert S, Karnjanabuch T, Leeaphorn N, Piyachomkwan K, Suwanwalaikorn S, Eiam-Ong S, Pongpirul K. Continuous glucose dynamics monitoring in diabetic patients with peritoneal dialysis. Chula Med J [Internet]. 2023 Aug. 24 [cited 2024 Nov. 22];61(4). Available from: https://he05.tci-thaijo.org/index.php/CMJ/article/view/462